Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome.
暂无分享,去创建一个
Matthias Schneider | G. Burmester | A. Krause | J. Braun | J. Listing | H. Sörensen | J. Sieper | R. Alten | X. Baraliakos | H. Haibel | S. Schewe | R. Schmidt | C. Fritz